Dover Corp Stock Soars to All-time High of $192.31
Carta Healthcare Survey: Clinical Registries Essential for Care Quality, But Data Quality Is Lacking
Citi Maintains Dover(DOV.US) With Buy Rating, Raises Target Price to $218
Citi analyst Andrew Kaplowitz maintains $Dover(DOV.US)$ with a buy rating, and adjusts the target price from $206 to $218.According to TipRanks data, the analyst has a success rate of 68.6% and a
Dover Chemical Corporation Partners With ISN to Improve Contractor Safety and Compliance
Are Investors Undervaluing Dover Corporation (NYSE:DOV) By 27%?
SEABOURN UNVEILS NEW 2026 SOLAR ECLIPSE SAILINGS; PROVIDING GUESTS A UNIQUE VIEWING OPPORTUNITY AT SEA FROM NORTHERN EUROPE AND THE MEDITERRANEAN